Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)

References

• Global cancer observatory [Internet]. 2020[accessed 2023 Jul 14]. https://gco.iarc.fr/.
   Google Scholar
• Bruni L, Albero G, Serrano B, Mena M, Collado J, Gómez D, Muñoz J, Bosch FX, de Sanjosé S; ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report. ICO/IARC HPV Information Centre; 2023 Mar 10.
   Google Scholar
• Douglawi A, Masterson TA. Updates on the epidemiology and risk factors for penile cancer. Transl Androl Urol [Internet]. 2017 Oct;6(5):785–8. doi:10.21037/tau.2017.05.19.
   PubMed Web of Science ®Google Scholar
• Vieira CB, Feitoza L, Pinho J, Teixeira-Júnior A, Lages J, Calixto J, Coelho R, Nogueira L, Cunha I, Soares F, et al. Profile of patients with penile cancer in the region with the highest worldwide incidence. Sci Rep [Internet]. 2020 Feb 19;10(1):2965. doi:10.1038/s41598-020-59831-5.
   PubMedGoogle Scholar
• Gil-Prieto R, Ester PV, Álvaro-Meca A, Rodríguez MSM, de Miguel AG. The burden of hospitalizations for anus and penis neoplasm in Spain (1997–2008). Hum Vaccin Immunother [Internet]. 2012 Feb 27;8(2):201–207. doi:10.4161/hv.18388.
   PubMed Web of Science ®Google Scholar
• López N, Gil-de-Miguel Á, Pascual-García R, Gil-Prieto R. Hospitalizations associated with malignant neoplasia and in situ carcinoma in the anus and penis in men and women during a 5-year period (2009–2013) in Spain: an epidemiological study. Hum Vaccin Immunother [Internet]. 2017 Oct 3;13(10):2292–2299. doi:10.1080/21645515.2017.1348443.
   PubMed Web of Science ®Google Scholar
• Oyouni AAA. Human papillomavirus in cancer: infection, disease transmission, and progress in vaccines. J Infect Public Health [Internet]. 2023 Apr;16(4):626–631. doi:10.1016/j.jiph.2023.02.014.
   PubMed Web of Science ®Google Scholar
• Engelsgjerd JS, LaGrange CA. Penile cancer [Internet]. StatPearls; 2023. http://www.ncbi.nlm.nih.gov/pubmed/30777241.
   Google Scholar
• de Sanjosé S, Serrano B, Tous S, Alejo M, Lloveras B, Quirós B, de Sanjosé S, Clavero O, Vidal A, Ferrándiz-Pulido C, et al. Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6/11/16/18/31/33/45/52 and 58. JNCI Cancer Spectr [Internet]. 2018 Oct 1;2(4). doi:10.1093/jncics/pky045/5278701.
   Google Scholar
• Hartwig S, St Guily JL, Dominiak-Felden G, Alemany L, de Sanjosé S. Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe. Infect Agent Cancer [Internet]. 2017 Dec 11;12(1):19. doi:10.1186/s13027-017-0129-6.
   PubMedGoogle Scholar
• De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP. The burden of human papillomavirus infections and related diseases in Sub-Saharan Africa. Vaccine [Internet]. 2013 Dec;31:F32–F46. doi:10.1016/j.vaccine.2012.07.092.
   PubMed Web of Science ®Google Scholar
• Brickman C, Palefsky JM. Human papillomavirus in the HIV-Infected host: epidemiology and pathogenesis in the antiretroviral era. Curr HIV/AIDS Rep [Internet]. 2015 Mar 3;12(1):6–15. doi:10.1007/s11904-014-0254-4.
   PubMed Web of Science ®Google Scholar
• Darwich L, Cañadas M-P, Videla S, Coll J, Molina-López RA, Sirera G, Clotet B. Prevalence, clearance, and incidence of human papillomavirus type–specific infection at the anal and penile site of HIV-Infected men. Sex Transm Dis [Internet]. 2013 Aug;40(8):611–618. doi:10.1097/01.OLQ.0000430798.61475.08.
   PubMed Web of Science ®Google Scholar
• eClinicalMedicine. Global strategy to eliminate cervical cancer as a public health problem: are we on track? EClinicalMedicine [Internet]. 2023 Jan;55:101842. doi:10.1016/j.eclinm.2023.101842.
   PubMedGoogle Scholar
• De La Fuente J, Hernandez Aguado JJ, San Martín M, Ramirez Boix P, Cedillo Gómez S, López N. Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain. Hum Vaccin Immunother [Internet]. 2019 Aug 3;15(7–8):1949–1961. doi:10.1080/21645515.2018.1560770.
   PubMed Web of Science ®Google Scholar
• Linertová R, Guirado-Fuentes C, Mar-Medina J, Teljeur C. Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain. Hum Vaccin Immunother [Internet]. 2022 Nov 30;18(6). doi:10.1080/21645515.2022.2127983.
   PubMed Web of Science ®Google Scholar
• Ministerio de Sanidad. Clasificación internacional de enfermedades 10.a Revisión, modificación clínica. Edición española [Internet]. 2022 [ accessed 2023 Jul 14]. https://eciemaps.mscbs.gob.es/ecieMaps/browser/index_10_mc.html#search=&flags=111100&flagsLT=11111111&searchId=1694621962087&indiceAlfabetico=&listaTabular=id-2-class-Tab.D&expand=0&clasification=cie10mc&version=2010.
   Google Scholar
• Rivero Cuadrado A. Análisis y desarrollo de los GDR en el Sistema Nacional de Salud [Internet]. Ministerio de Sanidad y Consumo; 1999[accessed 2023 Jul 14]. https://www.sanidad.gob.es/estadEstudios/estadisticas/docs/analisis.pdf.
   Google Scholar
• Schreyögg J, Stargardt T, Tiemann O, Busse R. Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries. Health Care Manag Sci [Internet]. 2006 Aug 20;9(3):215–223. doi:10.1007/s10729-006-9040-1.
   PubMedGoogle Scholar
• Kuhdari P, Previato S, Giordani M, Biavati P, Ferretti S, Gabutti G. The burden of HPV-related diseases in Italy, 2001–12. J Public Health (Bangkok) [Internet]. 2017 Dec 1;39(4):730–737. http://academic.oup.com/jpubhealth/article/39/4/730/3069103.
   PubMed Web of Science ®Google Scholar
• Östensson E, Silfverschiöld M, Greiff L, Asciutto C, Wennerberg J, Lydryp M-L, Håkansson U, Sparén P, Borgfeldt C. The economic burden of human papillomavirus-related precancers and cancers in Sweden. McLaughlin-Drubin M, editor. PLoS One [Internet]. 2017 Jun 26;12(6):e0179520. doi:10.1371/journal.pone.0179520.
   PubMed Web of Science ®Google Scholar
• Fabiano G, Marcellusi A, Mennini FS, Sciattella P, Favato G. Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis. Eur J Heal Econ [Internet]. 2023 Feb 13;24(1):75–80. 10.1007/s10198-022-01453-x.
   PubMed Web of Science ®Google Scholar
• López N, Torné A, Franco A, San-Martin M, Viayna E, Barrull C, Perulero N. Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine. Infect Agent Cancer [Internet]. 2018 Dec 2;13(1):15. doi:10.1186/s13027-018-0187-4.
   PubMedGoogle Scholar
• López N, Gil-de-Miguel Á, Pascual-García R, Gil-Prieto R. Reduction in the burden of hospital admissions due to cervical disease from 2003–2014 in Spain. Hum Vaccin Immunother. 2018;14(4):917–923. doi:10.1080/21645515.2017.1412897.
   PubMed Web of Science ®Google Scholar
• Galindo-Utrero A, San-Román-Montero JM, Gil-Prieto R, Gil-de-Miguel Á. Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020. BMC Cancer [Internet]. 2022;22(1):1–12. doi:10.1186/s12885-022-10205-2.
   PubMed Web of Science ®Google Scholar
• Carazo-Casas C, Gil-Prieto R, Hernández-Barrera V, Gil de Miguel Á. Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 2019. Hum Vaccines Immunother [Internet]. 2022;18(5). doi:10.1080/21645515.2022.2082192.
   PubMed Web of Science ®Google Scholar
• Qendri V, Bogaards JA, Baussano I, Lazzarato F, Vänskä S, Berkhof J. The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment. Lancet Public Heal [Internet]. 2020 Nov;5(11):e592–e603. https://linkinghub.elsevier.com/retrieve/pii/S2468266720302097.
   PubMed Web of Science ®Google Scholar
• Linertová R, Guirado-Fuentes C, Mar Medina J, Imaz-Iglesia I, Rodríguez-Rodríguez L, Carmona-Rodríguez M. Cost-effectiveness of extending the HPV vaccination to boys: a systematic review. J Epidemiol Community Health [Internet]. 2021 Sep;75(9):910–916. doi:10.1136/jech-2020-216305.
   PubMed Web of Science ®Google Scholar
• Grupo de trabajo de Vacunación frente a VPH en varones de la Ponencia de Programa y Registro de Vacunaciones. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud [Internet]. Ministerio de Sanidad; 2022. [accessed 2024 Jan 15]. https://web.mscbs.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/docs/Recomendaciones_vacunacion_VPHVarones.pdf.
   Google Scholar
• Simons JJM, Vida N, Westra TA, Postma MJ. Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands. Vaccine [Internet]. 2020 Jun;38(30):4687–4694. https://linkinghub.elsevier.com/retrieve/pii/S0264410X20306617.
   PubMed Web of Science ®Google Scholar
• Audisio RA, Icardi G, Isidori AM, Liverani CA, Lombardi A, Mariani L, Mennini FS, Mitchell DA, Peracino A, Pecorelli S, et al. Public health value of universal HPV vaccination. Crit Rev Oncol Hematol [Internet]. 2016 Jan;97:157–167. doi:10.1016/j.critrevonc.2015.07.015.
   PubMed Web of Science ®Google Scholar
• Della Salute M. Piano nazionale prevenzione vaccinale 2017–2019. Ministero della Salute: Italia; 2017. https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf.
   Google Scholar
• Asociación Española de Pediatría [Internet]. 2023 [accessed 2023 Jul 14]. https://vacunasaep.org/profesionales/calendario-vacunas.
   Google Scholar
• Mahumud RA, Alam K, Keramat SA, Ormsby GM, Dunn J, Gow J. Cost-effectiveness evaluations of the 9-valent human papillomavirus (HPV) vaccine: evidence from a systematic review. Grce M, editor. PLoS One [Internet]. 2020 Jun 2;15(6):e0233499. doi:10.1371/journal.pone.0233499.
   PubMed Web of Science ®Google Scholar
• St. Laurent J, Luckett R, Feldman S. HPV vaccination and the effects on rates of HPV-related cancers. Curr Probl Cancer [Internet]. 2018 Sep;42(5):493–506. https://linkinghub.elsevier.com/retrieve/pii/S0147027218301351.
   PubMed Web of Science ®Google Scholar
• Clifford GM, Combes J-D. Hopes for prevention of anal cancer in women. J Infect Dis [Internet]. 2019 Apr 23. doi:10.1093/infdis/jiz191.
   PubMed Web of Science ®Google Scholar
• Albuquerque A, Nathan M, Cappello C, Dinis-Ribeiro M. Anal cancer and precancerous lesions: a call for improvement. Lancet Gastroenterol Hepatol [Internet]. 2021 Apr;6(4):327–334. https://linkinghub.elsevier.com/retrieve/pii/S2468125320303046.
   PubMed Web of Science ®Google Scholar
• da Costa Nunes JF, Pires S, Chade DC. Human papillomavirus vaccination and prevention of intraepithelial neoplasia and penile cancer: review article. Curr Opin Urol [Internet]. 2020 Mar;30(2):208–212. doi:10.1097/MOU.0000000000000730.
   PubMed Web of Science ®Google Scholar
• Muñoz-Rodríguez J, Millán-Revilla L. The role of nurses in the prevention of anal cancer in HIV-infected men having sex with men – a focus on papillomavirus vaccination and anal cytology screening. AIDS Rev [Internet]. 2022 Dec 29;24(4). doi:10.24875/AIDSRev.M22000053.
   Google Scholar
• Larsen HK, Hædersdal M, Kjær SK. High-resolution anoscopy can diagnose precursors to anal cancer. Ugeskr Laeger [Internet]. 2023 Feb 27;185(9). http://www.ncbi.nlm.nih.gov/pubmed/36896618.
   Google Scholar
• Palefsky JM, Lee JY, Jay N, Goldstone SE, Darragh TM, Dunlevy HA, Rosa-Cunha I, Arons A, Pugliese JC, Vena D, et al. Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer. N Engl J Med [Internet]. 2022 Jun 16;386(24):2273–2282. doi:10.1056/NEJMoa2201048.
   PubMed Web of Science ®Google Scholar
• Marchioni M, Berardinelli F, De Nunzio C, Spiess P, Porpiglia F, Schips L, Cindolo L. New insight in penile cancer. Minerva Urol e Nefrol [Internet]. 2018 Dec;70(6). doi:10.23736/S0393-2249.18.03215-0.
   Google Scholar
• Marzo-Castillejo M, Bartolomé-Moreno C, Bellas-Beceiro B, Melús-Palazón E, Vela-Vallespín C. PAPPS expert groups. Cancer prevention recommendations: update 2022. Aten Primaria. 2022 Oct;54(Suppl 1):102440. doi:10.1016/j.aprim.2022.102440.
   PubMedGoogle Scholar
• Peiró S, Librero J. The quality assessment from the minimum basic hospital discharge data set. Rev Neurol [Internet]. 29(7):651–661. http://www.ncbi.nlm.nih.gov/pubmed/10599116.
   Google Scholar
• Penberthy L. Using hospital discharge files to enhance cancer surveillance. Am J Epidemiol [Internet]. 2003 Jul 1;158(1):27–34. doi:10.1093/aje/kwg108.
   PubMed Web of Science ®Google Scholar
• Rémy V, Mathevet P, Vainchtock A. Vulvar and vaginal cancers and dysplasia in France—an analysis of the hospital medical information system (PMSI) database. Eur J Obstet Gynecol Reprod Biol [Internet]. 2009 Dec;147(2):210–214. doi:10.1016/j.ejogrb.2009.08.011.
   PubMed Web of Science ®Google Scholar